326 related articles for article (PubMed ID: 27257963)
21. Autoimmune Extrahepatic Disorders in Patients With Autoimmune Liver Disease.
Contreras GV; Marugan MT; Cuervas-Mons V
Transplant Proc; 2021 Nov; 53(9):2695-2697. PubMed ID: 34593249
[TBL] [Abstract][Full Text] [Related]
22. The challenges of liver transplantation in children with primary sclerosing cholangitis.
Venkat VL; Ranganathan S; Sindhi R
Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):289-94. PubMed ID: 25592492
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune hepatitis in children: what is different from adult AIH?
Mieli-Vergani G; Vergani D
Semin Liver Dis; 2009 Aug; 29(3):297-306. PubMed ID: 19676002
[TBL] [Abstract][Full Text] [Related]
24. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
25. De novo autoimmune hepatitis -is this different in adults compared to children?
Kerkar N; Vergani D
J Autoimmun; 2018 Dec; 95():26-33. PubMed ID: 30396746
[TBL] [Abstract][Full Text] [Related]
26. Systematic review: recurrent autoimmune liver diseases after liver transplantation.
Montano-Loza AJ; Bhanji RA; Wasilenko S; Mason AL
Aliment Pharmacol Ther; 2017 Feb; 45(4):485-500. PubMed ID: 27957759
[TBL] [Abstract][Full Text] [Related]
27. Prospective evaluation of the prevalence and clinical significance of positive autoantibodies after pediatric liver transplantation.
Avitzur Y; Ngan BY; Lao M; Fecteau A; Ng VL
J Pediatr Gastroenterol Nutr; 2007 Aug; 45(2):222-7. PubMed ID: 17667719
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune hepatitis in children.
Mieli-Vergani G; Vergani D
Clin Liver Dis; 2002 Aug; 6(3):623-34. PubMed ID: 12362571
[TBL] [Abstract][Full Text] [Related]
29. Living donor liver transplantation during the first 3 months of life.
Kasahara M; Sakamoto S; Sasaki K; Uchida H; Kitajima T; Shigeta T; Narumoto S; Hirata Y; Fukuda A
Liver Transpl; 2017 Aug; 23(8):1051-1057. PubMed ID: 28220684
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory bowel disease in liver transplanted patients.
Filipec Kanizaj T; Mijic M
World J Gastroenterol; 2017 May; 23(18):3214-3227. PubMed ID: 28566881
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease.
Verdonk RC; Dijkstra G; Haagsma EB; Shostrom VK; Van den Berg AP; Kleibeuker JH; Langnas AN; Sudan DL
Am J Transplant; 2006 Jun; 6(6):1422-9. PubMed ID: 16686766
[TBL] [Abstract][Full Text] [Related]
32. Histologic surveillance after liver transplantation due to autoimmune hepatitis.
Puustinen L; Boyd S; Arkkila P; Isoniemi H; Arola J; Färkkilä M
Clin Transplant; 2017 May; 31(5):. PubMed ID: 28235132
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study.
Lewin M; Vilgrain V; Ozenne V; Lemoine M; Wendum D; Paradis V; Ziol M; Arrivé L; Beaugrand M; Poupon R; Valla D; Chazouillères O; Corpechot C
Hepatology; 2009 Aug; 50(2):528-37. PubMed ID: 19575454
[TBL] [Abstract][Full Text] [Related]
34. Juvenile autoimmune hepatitis: A comprehensive review.
Sokollik C; McLin VA; Vergani D; Terziroli Beretta-Piccoli B; Mieli-Vergani G
J Autoimmun; 2018 Dec; 95():69-76. PubMed ID: 30344030
[TBL] [Abstract][Full Text] [Related]
35. Liver transplantation for autoimmune hepatitis: a long-term pathologic study.
Ayata G; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
Hepatology; 2000 Aug; 32(2):185-92. PubMed ID: 10915722
[TBL] [Abstract][Full Text] [Related]
36. Long-term results of pediatric liver transplantation for autoimmune liver disease.
Couchonnal E; Jacquemin E; Lachaux A; Ackermann O; Gonzales E; Lacaille F; Debray D; Boillot O; Guillaud O; Wildhaber BE; Chouik Y; McLin V; Dumortier J
Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101537. PubMed ID: 33077391
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune sclerosing cholangitis: Evidence and open questions.
Terziroli Beretta-Piccoli B; Vergani D; Mieli-Vergani G
J Autoimmun; 2018 Dec; 95():15-25. PubMed ID: 30366655
[TBL] [Abstract][Full Text] [Related]
38. Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
Mouchli MA; Singh S; Boardman L; Bruining DH; Lightner AL; Rosen CB; Heimbach JK; Hasan B; Poterucha JJ; Watt KD; Kane SV; Raffals LE; Loftus EV
Inflamm Bowel Dis; 2018 Apr; 24(5):1074-1081. PubMed ID: 29522202
[TBL] [Abstract][Full Text] [Related]
39. Frequent overlap of active hepatitis in recurrent primary sclerosing cholangitis after living-donor liver transplantation relates to its rapidly progressive course.
Miyagawa-Hayashino A; Egawa H; Yoshizawa A; Ueda Y; Ichida T; Ueno Y; Uemoto S; Harada K; Nakanuma Y
Hum Pathol; 2011 Sep; 42(9):1329-36. PubMed ID: 21334714
[TBL] [Abstract][Full Text] [Related]
40. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
